Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04421729 · ClinicalTrials.gov registry record · NA

SoCal Savvy: Testing Savvy Caregiver in a Racially and Ethnically Diverse Sample in Southern California

A NA study, sponsored by University of Southern California.

Completed
Registry status
NA
Development phase
121
Enrollment target

NCT04421729: Completed NA study, sponsored by University of Southern California.

NCT04421729 is a NA study that has completed, run by University of Southern California. The registered enrollment target is 121 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (91% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04421729, a NA study, has completed, sponsored by University of Southern California.

COMPLETED
Registry status
NA
Development phase
121 participants
Enrollment target

Study Summary

The investigators will conduct a hybrid efficacy-effectiveness trial intended to address these gaps by testing the efficacy-effectiveness of two multi-family group interventions, and on 250 English-speaking adults: Savvy Caregiver Express™ (3-session, newly piloted in Los Angeles County for feasibility) and Savvy Caregiver Program (original 6-session evidenced-based intervention), across post-intervention, 3- and 6-months.

Primary Outcome

caregiver depressive symptoms

Interventions

  • BEHAVIORAL Group sessions over 3 weeks
  • BEHAVIORAL Group sessions over 6 weeks

Trial Details

FieldValue
Enrollment Target 121 participants
Start Date 2020-08-25
Est. Completion 2023-06-30
Phase NA
University of Southern California

617 total trials

What the finished NCT04421729 record still lists

NCT04421729 is an interventional study that assigns participants to a tested intervention. The registered 121 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (91% lower).

The record links to 0 conditions, and to 2 interventions - of which Group sessions over 3 weeks is the first listed.

NCT04421729 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT04421729 about?

NCT04421729 is a clinical study titled "SoCal Savvy: Testing Savvy Caregiver in a Racially and Ethnically Diverse Sample in Southern California". The investigators will conduct a hybrid efficacy-effectiveness trial intended to address these gaps by testing the efficacy-effectiveness of two multi-family group interventions, and on 250 English-speaking adults: Savvy Caregiver Express™ (3-session, newly piloted in Los Angeles County for feasibil...

What is the current status of trial NCT04421729?

This trial is currently completed. It is a NA study. The enrollment target is 121 participants. The study started on 2020-08-25. Estimated completion is 2023-06-30.

What interventions are being tested in trial NCT04421729?

The interventions under investigation include: Group sessions over 3 weeks (BEHAVIORAL), Group sessions over 6 weeks (BEHAVIORAL).

Who is sponsoring clinical trial NCT04421729?

This trial is sponsored by University of Southern California, which has 617 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT04421729's enrollment target sits among peer trials

121 762nd of 2000 higher than 1,239 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03476681 · 121 participants · Phase 1

    Study of NEO-201 in Solid Tumors Expansion Cohorts

  • NCT04655118 · 121 participants · Phase 2

    Study of TL-895 in Subjects With Myelofibrosis or Indolent Systemic Mastocytosis

  • NCT04676802 · 121 participants · Phase 2

    Pain Relief After Trapeziectomy: Ibuprofen & Acetaminophen Versus Oxycodone

  • NCT05169515 · 121 participants · Phase 1

    A Study Evaluating the Safety, Pharmacokinetics, and Efficacy of Mosunetuzumab or Glofitamab in Combination With CC-220 and/or CC-99282 in Participants With B-Cell Non-Hodgkin Lymphoma

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04421729, the US trial registry maintained by the National Library of Medicine. NCT04421729 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.